Ascentage Pharma Group International (AAPG) Current Assets (2023 - 2025)

Ascentage Pharma Group International (AAPG) has reported Current Assets for 3 consecutive years, with $415.1 million the latest figure, recorded in Q4 2025.

• Quarterly Current Assets rose 102.27% year-over-year to $415.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $415.1 million (up 102.27% YoY) and the FY2025 annual result came in at $421.0 million, up 108.46% from the prior year.
• Current Assets rose to $415.1 million in Q4 2025 per AAPG's latest filing, from $266.4 million in the prior quarter.
• Over the last five years, Current Assets for AAPG reached as high as $415.1 million in Q4 2025 and fell as low as $186.7 million in Q4 2023.
• A 3-year average of $268.4 million and a median of $235.8 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2024 — Current Assets advanced 9.93% — and 2025, when it surged 102.27%.
• Year by year, Current Assets stood at $186.7 million in 2023, then rose by 9.93% to $205.2 million in 2024, then jumped by 102.27% to $415.1 million in 2025.
• According to Business Quant data, Current Assets over the past three periods registered $415.1 million, $266.4 million, and $205.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.